A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2004
12/01/2004	EP1480687A1 Modified phosphocalcic compound, injectable composition containing same
12/01/2004	EP1480679A1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
12/01/2004	EP1480677A2 Composition for stabilizing hyaluronic acid
12/01/2004	EP1480673A1 A bioadhesive agent
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480664A2 Compositions and methods of use of peptides in combination with biocides and/or germicides
12/01/2004	EP1480661A1 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
12/01/2004	EP1480653A2 Ribavirin syrup formulations
12/01/2004	EP1480652A1 Use of phospholipids in peritoneal dialysis
12/01/2004	EP1480651A1 Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
12/01/2004	EP1480650A1 Novel crystalline forms of the anti-cancer compound zd1839
12/01/2004	EP1480649A2 Stable pharmaceutical compositions
12/01/2004	EP1480636A2 Self emulsifying drug delivery systems for poorly soluble drugs
12/01/2004	EP1480631A2 Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480625A1 Transdermal system comprising fentanyl
12/01/2004	EP1480624A2 Pharmaceutical tablet
12/01/2004	EP1480623A1 Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release
12/01/2004	EP1480622A1 Immediate release pharmaceutical granule compositions and a continuous process for making them
12/01/2004	EP1480621A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
12/01/2004	EP1480620A2 (ester)-lysolecithins in liposomes
12/01/2004	EP1480619A1 Drug carriers comprising amphiphilic block copolymers
12/01/2004	EP1480618A1 Sustained release drug formulations containing a carrier peptide
12/01/2004	EP1480617A2 Pressurised metered dose inhalers containing solutions of beta-2 agonists
12/01/2004	EP1480616A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
12/01/2004	EP1480615A1 Formoterol superfine formulation
12/01/2004	EP1480614A2 Emulsion containing hydrophobic nanodrops with bound hemoglobin molecules in a hydrophilic phase as a blood substitute
12/01/2004	EP1480613A1 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer
12/01/2004	EP1480602A2 Method for producing emulsions
12/01/2004	EP1480529A1 Method of colouring dragees and the composition used
12/01/2004	EP1480517A2 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
12/01/2004	EP1435787A4 Nestin-expressing hair follicle stem cells
12/01/2004	EP1240230A4 Swelling and deswelling polymer blends
12/01/2004	EP1214093B1 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants and corresponding products
12/01/2004	EP1196383B1 Process for preparing amlodipine benzenesulphonate
12/01/2004	EP1180023B1 Substrate sections with improved storage stability during their storage in bags
12/01/2004	EP1173197B1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
12/01/2004	EP1153616B1 Tablets quickly disintegrated in the oral cavity
12/01/2004	EP1121449A4 Delivery system for porcine somatotropin
12/01/2004	EP1117388A4 Antioxidant gel for gingival conditions
12/01/2004	EP1117386B1 Enteric and colonic delivery using hpmc capsules
12/01/2004	EP1061961B1 Apparatuses and processes for whole-body hyperthermia
12/01/2004	EP1059943B1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/01/2004	EP1056462A4 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
12/01/2004	EP1044688B1 Method for solubilizing pyridonecarboxylic acids and aqueous solutions containing pyridonecarboxylic acids
12/01/2004	EP0994697B1 Rapamycin formulations for oral administration
12/01/2004	EP0966974B1 Antibacterial composition for topical administration containing faropenem
12/01/2004	EP0961610B1 Skin preparation
12/01/2004	EP0954293B1 Time-specific controlled release dosage formulations and method of preparing same
12/01/2004	EP0953009B1 A process for preparing polymeric microgels
12/01/2004	CN2659433Y Multiple coating recovery patch
12/01/2004	CN1551785A Sustained release of microcrystalline peptide suspensions
12/01/2004	CN1551784A Prostaglandin compositions and methods of treatment for male erectile dysfunction
12/01/2004	CN1551771A Method and composition for treatment of cancer
12/01/2004	CN1551770A Sustained release formulations of oxymorphone
12/01/2004	CN1551768A Substituted benzimidazole dosage forms and method of using same
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1551759A Oily thixotropic formulations
12/01/2004	CN1551758A Process for dispersing a fluid in solid particles
12/01/2004	CN1550504A Process of high purity albumin production
12/01/2004	CN1550233A Skin patch and method for administering testosterone
12/01/2004	CN1550230A Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof
12/01/2004	CN1177903C Process for stabilizing gelatin products
12/01/2004	CN1177884C Spherical microparticles containing linear polysaccharides
12/01/2004	CN1177808C Solid compositions suitable for oral administration composing L-carnitine and alkanoyl-L-carnitine mangesium tartrate
12/01/2004	CN1177787C Powder shape mannitol and process for preparing same
12/01/2004	CN1177614C Slow releasing composition
12/01/2004	CN1177612C Composition for sustained release of non-aggregated erythropoietin
12/01/2004	CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/01/2004	CN1177608C Preparation of erosion of cervix
12/01/2004	CN1177603C Ginkg leaf slow-releasing tablet
12/01/2004	CN1177599C Chinese medicine for treating burn and scald and its preparing process
12/01/2004	CN1177595C Use of composition for increasing insulin activity
12/01/2004	CN1177594C Formulation for use in prevention of pathogen induced diseases including HIV and HSV
12/01/2004	CN1177590C Cyclophosphamide coated tablets
12/01/2004	CN1177589C Analgesic combination
12/01/2004	CN1177588C Coated dosage unit
12/01/2004	CN1177585C Patch
12/01/2004	CN1177584C Solid active agent preparations
12/01/2004	CN1177582C Pharmaceutical aerosol compsn. contg. HFA227 and HFA 134a
12/01/2004	CN1177581C Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
11/2004
11/30/2004	US6825350 Administering dosage of immunology response moderator
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825234 Compositions and methods for amelioration of human female sexual dysfunction
11/30/2004	US6825226 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
11/30/2004	US6825218 Encapsulated crystal form for oral suspensions without bad taste
11/30/2004	US6825031 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance
11/30/2004	US6824822 Residual solvent extraction method and microparticles produced thereby
11/30/2004	US6824793 Bioadhesive properties of the hyaluronic acid polymers decrease the rate of mucociliary clearance from the nasal cavity and thus allow a longer contact time between the antigen and the absorbing membrane
11/30/2004	US6824792 Heat treating polymer mixture of a natural or synthetic polycarboxylated polymer and at least one polysaccharide to effect crosslinking
11/30/2004	US6824791 Methods for micronization of hydrophobic drugs
11/30/2004	US6824790 Capsule, tablet with enteric, protective coatings; bioavailability
11/30/2004	US6824762 Nasal spray compositions
11/30/2004	US6824761 Anti-asthmatic combinations comprising surface active phospholipids
11/30/2004	US6824561 Implantable system with drug-eluting cells for on-demand local drug delivery
11/30/2004	US6824557 Steam generator
11/30/2004	US6824538 System for preventing sudden cardiac death by nerve sprouting from right stellate ganglion
11/30/2004	CA2396441C Diclofenamide suspension gel
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2265461C Compositions and methods for topical application of therapeutic agents

1 ... 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 ... 2991